The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines ...

More recently, a study revealed that three of nearly 20,000 people who got Moderna's vaccines and booster had significant adverse effects ... As for concerns about the heart issue, myocarditis, a ...

Another round of SARS-CoV-2 booster vaccines are being offered, but will another booster reduce our risk of COVID-19 disease? This is a question on the minds of many, including Dr. Bo Zhang, an ...

Quick Takes A booster dose of vaccine was associated with increased risk of myocarditis within 28 days of vaccination in 12- to 39-year-old males with incident rates of 0.86 per 100,000 vaccinated ...

Called mRNA-1273.214, Moderna’s new Omicron booster specifically targets Omicron strains of COVID-19, along with “the ancestral strain” of SARS-CoV-2, the virus that causes COVID-19, says ...

Moderna announced new data on Wednesday suggesting a new version of its COVID-19 vaccine will offer superior protection to its original formulation of shots, based on studying antibodies generated ...

To test the bivalent BA.1-targeting booster, Moderna recruited 814 adults (age 18 to over 65) who had gotten a primary series of Moderna vaccines (two 100-microgram shots) plus a shot of the ...